References
- Alkatout I, Schubert M, Garbrecht N, Weigel MT, Jonat W, Mundhenke C, et al. Vulvar cancer: epidemiology, clinical presentation, and management options. Int J Womens Health 2015; 7: 305-13. doi: 10.2147/IJWH.S68979
- Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, et al. European Society of Gynaecological Oncology Guidelines for the management of patients with vulvar cancer. Int J Gynecol Cancer 2017; 27: 832-7. doi: 10.1097/IGC.0000000000000975
- Cancer Registry of Republic of Slovenia [Internet] 2016 [cited 2020 May 6]. Available from: https://www.onko-i.si/rrs/
- Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47-55. doi:1 0.1515/raon-2017-0008
- Cancer in Slovenia 2016. Ljubljana: Cancer in Slovenia 2016. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Slovenian Cancer Registry; [internet] 2019 [cited 2020 May 12]. Available from: https://www.onko-i.si/fileadmin/onko/datoteke/dokumenti/RRS/LP_2016.pdf
- De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014; 15: 23-34. doi: 10.1016/S1470-2045(13)70546-1
- Del Pino M, Rodriguez-Carunchio L, Ordi J. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Histopathology 2013; 62: 161-75. doi: 10.1111/his.12034
- Pils S, Gensthaler L, Alemany L, Horvat R, de Sanjosé S, Joura EA. HPV prevalence in vulvar cancer in Austria. Wien Klin Wochenschr 2017; 129: 805-9. doi: 10.1007/s00508-017-1255-2
- Wohlmuth C, Wohlmuth-Wieser I. Vulvar malignancies: an interdisciplinary perspective. J Dtsch Dermatol Ges 2019; 17: 1257-76. doi: 10.1111/ddg.13995
- Angelico G, Santoro A, Inzani F, Spadola S, Fiorentino V, Cianfrini F, et al. Ultrasound-guided FNA cytology of groin lymph nodes improves the management of squamous cell carcinoma of the vulva: results from a comparative cytohistological study. Cancer Cytopathol 2019; 127: 514-20. doi: 10.1002/cncy.22154
- de Gregorio N, Ebner F, Schwentner L, Friedl TWP, Deniz M, Látó K, et al. The role of preoperative ultrasound evaluation of inguinal lymph nodes in patients with vulvar malignancy. Gynecol Oncol 2013; 131: 113-7. doi: 10.1016/j.ygyno.2013.07.103
- Kataoka MY, Sala E, Baldwin P, Reinhold C, Farhadi A, Hudolin T, et al. The accuracy of magnetic resonance imaging in staging of vulvar cancer: a retrospective multi-centre study. Gynecol Oncol 2010; 117: 82-7. doi: 10.1016/j. ygyno.2009.12.017
- Andersen K, Zobbe V, Thranov IR, Pedersen KD. Relevance of computerized tomography in the preoperative evaluation of patients with vulvar cancer: a prospective study. Cancer Imaging 2015; 15: 8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470090/ doi: 10.1186/s40644-015-0044-2
- Cham S, Chen L, Burke WM, Hou JY, Tergas AI, Hu JC, et al. Utilization and outcomes of sentinel lymph node Biopsy for vulvar cancer. Obstet Gynecol 2016; 128: 754-60. doi: 10.1097/AOG.0000000000001648
- Huang J, Yu N, Wang X, Long X. Incidence of lower limb lymphedema after vulvar cancer: a systematic review and meta-analysis. Medicine 2017; 96: 8722. doi: 10.1097/MD.0000000000008722
- Slomovitz BM, Coleman RL, Oonk MHM, van der Zee A, Levenback C. Update on sentinel lymph node biopsy for early-stage vulvar cancer. Gynecol Oncol 2015; 138: 472-7. doi: 10.1016/j.ygyno.2015.05.017
- Oonk MHM, Hollema H, van der Zee AGJ. Sentinel node biopsy in vulvar cancer: implications for staging. Best Pract Res Clin Obstet Gynaecol 2015; 29: 812-21. doi: 10.1016/j.bpobgyn.2015.03.007
- Zigras T, Kupets R, Barbera L, Covens A, Liu Y, Gien LT. Uptake of sentinel lymph node procedures in women with vulvar cancer over time in a population based study. Gynecol Oncol 2019; 153: 574-9. doi: 10.1016/j. ygyno.2019.03.010
- Brincat MR, Muscat Baron Y. Sentinel lymph node biopsy in the management of vulvar carcinoma: an evidence-based insight. Int J Gynecol Cancer 2017; 27: 1769-73. doi: 10.1097/IGC.0000000000001075
- van Doorn HC, van Beekhuizen HJ, Gaarenstroom KN, van der Velden J, van der Zee AGJ, Oonk MHM, et al. Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible. Gynecol Oncol 2016; 140: 415-9. doi: 10.1016/j.ygyno.2016.01.013
- Verbeek FPR, Tummers QRJG, Rietbergen DDD, Peters AAW, Schaafsma BE, van de Velde CJH, et al. Sentinel lymph node biopsy in vulvar cancer using combined radioactive and fluorescence guidance. Int J Gynecol Cancer 2015; 25: 1086-93. doi: 10.1097/IGC.0000000000000419
- Ghoniem K, Shazly SA, Dinoi G, Zanfagnin V, Glaser GE, Mariani A. Sentinel lymph nodes and precision surgery in gynecologic cancer. Clin Obstet Gynecol 2020; 63: 12-23. doi: 10.1097/GRF.0000000000000517
- Van der Zee AGJ, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008; 26: 884-9. doi: 10.1200/JCO.2007.14.0566
- Mitra S, Sharma MK, Kaur I, Khurana R, Modi KB, Narang R, et al. Vulvar carcinoma: dilemma, debates, and decisions. Cancer Manag Res 2018; 10: 61-8. doi: 10.2147/CMAR.S143316
- Swanick CW, Eifel PJ, Huo J, Meyer LA, Smith GL. Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer. Gynecol Oncol 2017; 146: 87-93. doi: 10.1016/j. ygyno.2017.05.004
- Deppe G, Mert I, Belotte J, Winer IS. Chemotherapy of vulvar cancer: a review. Wien Klin Wochenschr 2013; 125: 119-28. doi: 10.1007/s00508-013-0338-y
- Domingues AP, Mota F, Durão M, Frutuoso C, Amaral N, de Oliveira CF. Neoadjuvant chemotherapy in advanced vulvar cancer. Int J Gynecol Cancer 2010; 20: 294-8. doi: 10.1111/igc.0b013e3181c93adc
- Inrhaoun H, Elghissassi I, Gutierrez M, Brain E, Errihani H. Long term response to erlotinib in a patient with recurrent vulvar carcinoma: case report and review of literature. Gynecol Oncol Case Rep 2012; 2: 119-20. doi: 10.1016/j.gynor.2012.07.002
- Horowitz NS, Olawaiye AB, Borger DR, Growdon WB, Krasner CN, Matulonis UA, et al. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecologic Oncology 2012; 127: 141-6. doi: 10.1016/j. ygyno.2012.06.028
- Schnürch HG, Ackermann S, Alt-Radtke CD, Angleitner L, Barinoff J, Beckmann MW, et al. Diagnosis, therapy and follow-up of vaginal cancer and its precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018). Geburtshilfe Frauenheilk 2019; 79: 1060-78. doi: 10.1055/a-0919-4959